Attention deficit hyperactivity disorder risk, mental health diagnoses and experience of discrimination in transgender adolescents and youth

CONCLUSIONS: The ASRS-V1.1 scale may be useful for ADHD screening in transgender individuals; however, further studies are needed to confirm these findings. Risk factors for neurodevelopmental and anxiety-depressive disorders may differ in the transgender population.

via https://pubmed.ncbi.nlm.nih.gov/40946028/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20250914010806&v=2.18.0.post9+e462414